Newer Immunosuppressive Drugs
- 1 January 2002
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 62 (6), 891-907
- https://doi.org/10.2165/00003495-200262060-00003
Abstract
Rheumatoid arthritis (RA) is a chronic immune-mediated disease characterised by chronic synovitis, which leads to cartilage damage and joint destruction. It is generally a progressive disease with...Keywords
This publication has 97 references indexed in Scilit:
- The role of p38 mitogen‐activated protein kinase in IL‐6 and IL‐8 production from the TNF‐α‐ or IL‐1β‐stimulated rheumatoid synovial fibroblastsFEBS Letters, 1999
- Pyridinylimidazole Compound SB 203580 Inhibits the Activity but Not the Activation of p38 Mitogen-Activated Protein KinaseBiochemical and Biophysical Research Communications, 1999
- Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleusCurrent Biology, 1995
- SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1FEBS Letters, 1995
- Activation of the MAP kinase homologue RK requires the phosphorylation of Thr‐180 and Tyr‐182 and both residues are phosphorylated in chemically stressed KB cellsFEBS Letters, 1995
- THE PATHOGENESIS OF RHEUMATOID ARTHRITIS: FROM MOLECULES TO THE WHOLE PATIENTRheumatology, 1993
- Transcription factor interactions: basics on zippersCurrent Opinion in Structural Biology, 1991
- RS-61443—A NEW, POTENT IMMUNOSUPPRESSIVE AGENTTransplantation, 1991
- Rheumatoid ArthritisNew England Journal of Medicine, 1990
- Immunosuppressive effect of FK506 on collagen-induced arthritis in ratsClinical Immunology and Immunopathology, 1988